Your drug development solution provider

model-informed-pediatric-development-applied-to-bilastine-ontogenic-pk-model-development-dose-selection-for-first-time-in-children-and-pk-study-design

7 noviembre, 2017

Contact us

We wish to know from you,
we wish to help you.

I accept the terms of use.